Cargando…

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

Previous studies in experimental autoimmune encephalomyelitis (EAE) models have shown that some probiotic bacteria beneficially impact the development of this experimental disease. Here, we tested the therapeutic effect of two commercial multispecies probiotics—Lactibiane iki and Vivomixx—on the cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calvo-Barreiro, Laura, Eixarch, Herena, Ponce-Alonso, Manuel, Castillo, Mireia, Lebrón-Galán, Rafael, Mestre, Leyre, Guaza, Carmen, Clemente, Diego, del Campo, Rosa, Montalban, Xavier, Espejo, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226819/ https://www.ncbi.nlm.nih.gov/pubmed/32272791 http://dx.doi.org/10.3390/cells9040906

Ejemplares similares

Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis
por: Calvo-Barreiro, Laura, et al.
Publicado: (2021)

Therapeutic Effect of IL-21 Blockage by Gene Therapy in Experimental Autoimmune Encephalomyelitis
por: Edo, Ángel, et al.
Publicado: (2022)

Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE
por: Marín, Nieves, et al.
Publicado: (2014)

Hsp70 Regulates Immune Response in Experimental Autoimmune Encephalomyelitis
por: Mansilla, M. José, et al.
Publicado: (2014)

Immunomodulatory Effects Associated with Cladribine Treatment
por: Fissolo, Nicolás, et al.
Publicado: (2021)

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor
por: Miralles, Marta, et al.
Publicado: (2017)

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process
por: Mestre, Leyre, et al.
Publicado: (2020)

Molecular signature associated with cladribine treatment in patients with multiple sclerosis
por: Fissolo, Nicolas, et al.
Publicado: (2023)

Gut dysbiosis and neuroimmune responses to brain infection with Theiler’s murine encephalomyelitis virus
por: Carrillo-Salinas, F. J., et al.
Publicado: (2017)

The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis
por: Benítez-Fernández, Rocio, et al.
Publicado: (2022)

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis
por: Mestre, Leyre, et al.
Publicado: (2019)

Tolerogenic dendritic cells in experimental autoimmune encephalomyelitis, specific tolerance induction?
por: Sellés-Moreno, Carla, et al.
Publicado: (2012)

Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis
por: Cavalcanti, Fernando, et al.
Publicado: (2022)

Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus
por: Mecha, Miriam, et al.
Publicado: (2013)

Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
por: Mecha, Miriam, et al.
Publicado: (2020)

Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis
por: Mestre, Leyre, et al.
Publicado: (2021)

Tolerogenic Lipid Nanoparticles for Delivering Self-Antigen mRNA for the Treatment of Experimental Autoimmune Encephalomyelitis
por: Gomi, Masaki, et al.
Publicado: (2023)

A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
por: Carrillo-Salinas, Francisco J., et al.
Publicado: (2014)

Protocol to assess the tolerogenic properties of adoptively transferred dendritic cells during murine experimental autoimmune encephalomyelitis
por: Vogel, Andrea, et al.
Publicado: (2022)

Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA
por: Derdelinckx, Judith, et al.
Publicado: (2019)

Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance
por: Zhou, Yan, et al.
Publicado: (2016)

Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
por: Hernangómez, Miriam, et al.
Publicado: (2014)

Involvement of Wnt7a in the role of M2c microglia in neural stem cell oligodendrogenesis
por: Mecha, Miriam, et al.
Publicado: (2020)

Treatment with MOG-DNA vaccines induces CD4(+)CD25(+)FoxP3(+) regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis
por: Fissolo, Nicolás, et al.
Publicado: (2012)

Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1 )receptors
por: Mestre, Leyre, et al.
Publicado: (2011)

Neurofilament light chain level is a weak risk factor for the development of MS
por: Arrambide, Georgina, et al.
Publicado: (2016)

Tolerogenic Nanoparticles Induce Antigen-Specific Regulatory T Cells and Provide Therapeutic Efficacy and Transferrable Tolerance against Experimental Autoimmune Encephalomyelitis
por: LaMothe, Robert A., et al.
Publicado: (2018)

Inhibitory effects of tolerogenic probiotics on migratory potential of lupus patient-derived DCs
por: Esmaeili, Seyed-Alireza, et al.
Publicado: (2021)

Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020)

Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
por: Baradaran Ghavami, Shaghayegh, et al.
Publicado: (2021)

Oral Administration of Probiotic Enterococcus durans to Ameliorate Experimental Autoimmune Encephalomyelitis in Mice
por: Samani, Seyed Abdollah, et al.
Publicado: (2022)

Tolerogenic and Activatory Plasmacytoid Dendritic Cells in Autoimmunity
por: Guéry, Leslie, et al.
Publicado: (2013)

Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity
por: Passeri, Laura, et al.
Publicado: (2021)

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy
por: Navarrete, Carmen, et al.
Publicado: (2018)

Tolerogenic therapies in transplantation
por: Page, Eugenia K., et al.
Publicado: (2012)

Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment
por: Dolpady, Jayashree, et al.
Publicado: (2016)

Tolerogenic vaccines for Multiple Sclerosis
por: Mannie, Mark D., et al.
Publicado: (2013)

Tolerogenic citrullinated peptide for arthritis
por: Gertel, Smadar, et al.
Publicado: (2015)

Organ-Specific Autoimmune Disease: A Deficiency of Tolerogenic Stimulation
por: Lesage, Sylvie, et al.
Publicado: (2001)

Web Alert: Commercial probiotic microorganisms
por: Wackett, Lawrence P.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_egviptpvsk0ie9228qrms7ff1b